Logo
Clinell Peracetic Acid Wipes Pack of 25 CLEARANCE SHORT DATE 01/26

Clinell Peracetic Acid Wipes Pack of 25 CLEARANCE SHORT DATE 01/26

Clinell

Infection Control
  • Conforms to EN1275 (fungicidal activity).
  • Conforms to EN1276 (bactericidal activity).
  • Conforms to EN13704 (sporicidal activity).
  • Conforms to EN14348 (mycobactericidal activity).
  • Conforms to EN14476 (virucidal activity).
  • Conforms to EN14561 (bactericidal activity for instruments).
  • Conforms to EN14562 (fungicidal/yeasticidal activity for instruments).
  • Conforms to EN14563 (mycobactericidal/sporicidal activity for instruments).
  • Classified under Regulation (EC) No 1272/2008 (CLP) as Eye Dam. 1; signal word "Danger"; hazard statements including H318 (causes serious eye damage) per Safety Data Sheet.
  • SDS issued in accordance with Regulation (EU) 2020/878 and Regulation (EC) No 1272/2008, with latest version dated 21 January 2025.
  • Results from clinical and laboratory studies demonstrate significant reductions in C. difficile infection rates and broad efficacy against high Risk organisms and dry surface biofilms, as summarised in the manufacturer’s evidence brochure.
Peracetic acid sporicidal surface wipes

Description

Clinell Peracetic Acid Wipes - Pack of 25 (CS25) are high-performance peracetic acid–generating sporicidal wipes for surface disinfection and cleaning of non-invasive medical devices. Supplied here as a clearance line with a short expiry date of 01/2026, each pack contains 25 dry, single-use non-woven wipes impregnated with a solid powder system. When moistened with water, the wipe generates a powerful, pH-optimised blend of peracetic acid and hydrogen peroxide (from sodium percarbonate/perborate and tetraacetylethylenediamine) that provides high-level oxidative kill against all major microorganism groups, including bacterial spores, mycobacteria, fungi, viruses and dry surface biofilms. Clinically proven to reduce Clostridioides (Clostridium) difficile infections by 72%, these wipes are more effective than chlorine products yet kinder to surfaces due to a near-neutral pH, and are designed as an outbreak tool to complement everyday disinfectants such as Clinell Universal Wipes. They conform to multiple European standards (EN1275, EN1276, EN13704, EN14348, EN14476, EN14561, EN14562 and EN14563) and are supplied as single-use sporicidal wipes for use in hospitals, care homes, dental surgeries and other high-risk clinical environments.

Bnefits

  • High-level sporicidal disinfection: powerful oxidative technology based on peracetic acid and hydrogen peroxide, active against all major microorganism groups including bacterial spores, mycobacteria, fungi, viruses and biofilms.
  • More effective than chlorine against hard-to-kill organisms, spores and dry surface biofilms, offering a safer and less damaging alternative to regular chlorine use on many surfaces.
  • Clinically proven to reduce Clostridioides (Clostridium) difficile infections by approximately 72% in healthcare settings when used as part of outbreak and environmental decontamination protocols.
  • Ideal for preventing and resolving outbreaks, providing rapid, high-level disinfection of high-risk areas and equipment when used in conjunction with routine disinfectants such as Clinell Universal Wipes.
  • Near-neutral pH once activated, helping to minimise surface damage while maintaining extremely high antimicrobial activity.
  • Effective from 10 seconds for many bacteria, with defined, short contact times for spores, mycobacteria, fungi and viruses (e.g. C. difficile spores in 2 minutes, B. subtilis spores in 5 minutes, many bacteria in 10 seconds).
  • Dry wipe format with on-demand activation: peracetic acid is generated only when water is added, improving storage stability and reducing chemical exposure risk when the product is dry.
  • Single-use wipes support good infection-prevention practice by avoiding re-use of cloths and reducing cross-contamination between surfaces.
  • 5× typical surface coverage compared with many standard disinfectant wipes due to the unique wipe construction and chemistry, improving cost-effectiveness in outbreak situations.
  • Conforms to multiple European standards for bactericidal, fungicidal, mycobactericidal, virucidal and sporicidal activity (EN1275, EN1276, EN13704, EN14348, EN14476, EN14561, EN14562 and EN14563).

Indications

  • Surface disinfection and cleaning of non-invasive medical devices such as infusion pumps, monitors, trolleys, commodes (external surfaces), bed frames and other patient-contact equipment, according to manufacturer guidance.
  • High-level environmental decontamination during outbreaks or incidents involving C. difficile, other spore-forming organisms, multidrug-resistant organisms, and other high-risk pathogens.
  • Terminal cleaning of isolation rooms, side rooms, bathrooms and high-risk areas where enhanced sporicidal disinfection is required.
  • Use in theatres, intensive care units, oncology units, renal units, gastroenterology and other high-risk hospital departments in line with local infection-prevention protocols.
  • Decontamination of surfaces and equipment in care homes, dental practices, podiatry clinics and other healthcare environments where spore-forming or highly resistant organisms may be present.
  • Use as a complement to routine disinfectant wipes (e.g. Clinell Universal) when additional high-level sporicidal disinfection is required, such as during outbreak control and deep cleans.

Composition

  • Solid powder system within a non-woven wipe that generates peracetic acid and hydrogen peroxide upon the addition of water.
  • Sodium percarbonate (≤50% w/w) – oxidising agent that releases hydrogen peroxide and contributes to peracetic acid generation.
  • Citric acid (≤15% w/w) – acidulant helping optimise pH and support peracetic acid formation.
  • Tetraacetylethylenediamine (TAED) (≤25% w/w) – activator that reacts with hydrogen peroxide to generate peracetic acid.
  • Other formulation excipients in low concentrations to support stability, pH control and performance (exact proprietary composition as per manufacturer).
  • When activated with water, the system produces peracetic acid, hydrogen peroxide and acetic acid which rapidly degrade to non-persistent breakdown products (water, oxygen and acetate).

Formulation

  • Dry, non-woven single-use wipes containing solid powder particles which are inactive until moistened with water.
  • Peracetic acid–generating system based on sodium percarbonate/perborate and tetraacetylethylenediamine, producing a pH-optimised mixture of peracetic acid and hydrogen peroxide on activation.
  • Near-neutral pH once activated, designed to be powerful against microorganisms yet kind to compatible surfaces.
  • Sporicidal, mycobactericidal, fungicidal and virucidal low-residue formulation intended for high-level surface disinfection in healthcare environments.

Packaging

  • Flow-wrap pack containing 25 dry peracetic acid–generating wipes.
  • Typical wipe size approximately 21 × 30 cm (300 × 210 mm), providing large surface coverage per wipe.
  • Pack printed with Clinell branding, product name (Peracetic Acid Wipes / Sporicidal Wipes), key claims (e.g. more effective than chlorine, sporicidal), usage instructions, hazard symbols and regulatory information.
  • GAMA product code CS25; packs are often supplied in outers (e.g. 6 packs × 25 wipes) for hospital and institutional supply.
  • Clearance product note on specific batches indicating short expiry (01/2026) on outer label and/or Medisave listing.

Usage

  • Wear appropriate personal protective equipment, including gloves and eye protection, as recommended by the manufacturer and local risk assessment. These wipes must always be used with gloves.
  • Ensure the surface or non-invasive medical device is visibly clean where possible; heavy soiling should be removed prior to disinfection according to local cleaning protocols.
  • Remove a single dry wipe from the pack and reseal the pack immediately to keep the remaining wipes dry.
  • Activate the wipe by thoroughly wetting it with clean water (e.g. from a tap or clean water container), ensuring the entire wipe is evenly moistened but not dripping excessively.
  • Allow a brief activation time (as per local protocol / product instructions) to ensure peracetic acid generation; the wipe will have a slight vinegar-type odour when activated.
  • Wipe the target surface or equipment methodically, ensuring complete coverage and that sufficient solution is applied to keep the surface visibly wet for the required contact time.
  • Adhere to the required microbiological contact times: many vegetative bacteria are inactivated from 10 seconds; C. difficile and other spores typically require up to 2–5 minutes; refer to local efficacy tables or product literature for specific pathogens.
  • Do not rinse the surface after use unless specifically required by equipment manufacturer instructions; allow the surface to air-dry.
  • Discard each wipe after single use; do not re-dip or reuse on additional surfaces to avoid cross-contamination.
  • Use additional wipes as needed for larger areas or heavily contaminated surfaces.
  • Dispose of used wipes and any contaminated materials as clinical or hazardous waste according to local regulations; do not flush wipes down toilets.
  • Use only on compatible surfaces and always follow local infection-prevention policies, equipment manufacturer instructions and the product’s Instructions for Use.

Contraindications

  • Not intended for direct use on skin, mucous membranes or wounds; this product is for surface disinfection and the cleaning of non-invasive medical devices only.
  • Do not use on invasive or critical medical devices that require sterilisation or high-level disinfection by validated automated processes.
  • Avoid use on surfaces or materials known to be incompatible with strong oxidising agents (e.g. some metals, textiles or delicate finishes) without prior compatibility assessment.
  • Do not mix or use simultaneously with other chemical products (especially other oxidising agents or chlorine-releasing agents), as this may reduce efficacy or release hazardous vapours.
  • Avoid contact with eyes and face; activated solution is corrosive to eyes and may cause serious eye damage.
  • Not for ingestion; once activated, the peracetic acid solution may be harmful if swallowed.
  • Use only in well-ventilated areas, particularly when treating large surfaces, to limit exposure to vapours (acetic acid/peracetic acid).

Adverse Effects

  • Contact with activated solution may cause serious eye damage (risk of permanent injury) if splashed into the eyes.
  • Activated solution may cause irritation or, with prolonged contact, potential corrosive effects on skin; wearing gloves is mandatory and protective clothing is recommended for extensive use.
  • Inhalation of vapours (especially in confined or poorly ventilated spaces) may cause respiratory or throat irritation in some individuals.
  • Ingestion of activated solution may cause irritation or corrosion of the mouth, throat and gastrointestinal tract and requires immediate medical attention.
  • Dry product and activated solution are oxidising and may, in large quantities or misuse scenarios, contribute to the combustion of flammable materials.
  • Rarely, individuals may experience hypersensitivity or allergic-type reactions to components of the formulation; discontinue exposure and seek medical advice if such reactions occur.

Storage Conditions

  • Store in a cool, dry, well-ventilated place away from direct sunlight and sources of heat.
  • Keep the pack tightly closed when not in use and protect from moisture and high humidity; the product must remain dry in the packaging until activation.
  • Keep away from combustible materials, reducing agents and other incompatible substances, as the dry product is an oxidising preparation.
  • Avoid temperatures above approximately 50°C, as decomposition of the powder system may occur at elevated temperatures.
  • Do not store near open water sources or in areas where the packs can become saturated or accidentally wetted prior to use.
  • Keep out of reach of children and unauthorised persons, in line with local chemical and infection-control policies.

Duration

Used for individual cleaning and disinfection episodes. Each wipe is single-use and provides one activation and application. Surfaces and devices should be re-disinfected whenever they become contaminated, between patients and as part of routine and terminal cleaning schedules, in line with local infection-prevention protocols.

Onset

Rapid; antimicrobial activity begins immediately once the wipe is activated with water and applied. Many bacteria are killed from around 10 seconds, with spores (including C. difficile), mycobacteria, fungi and viruses typically requiring contact times from 1 to 5 minutes depending on the organism and test standard.

Browse more Infection Control

Top Treatments

Top Cities in the UK